Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts

Transplantation

Volumn 74, Issue 2, 2002, Pages 268-277

  Sumitran Holgersson, S ^a   Wilczek, H E ^a   Holgersson, J ^a   Soderstrom, K ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HLA ANTIBODY; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 RELATED CHAIN A; MICA ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMORAL IMMUNITY; KIDNEY ALLOGRAFT REJECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0037183186     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200207270-00019     Document Type: Article

References (30)

1. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells
2. Positive crossmatches: When is it safe to transplant?
3. The clinical importance of choosing the right assay for detection of HLA-specific donor-reactive antibodies
4. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome
5. The association of antivascular endothelial cell antibody with hyperacute rejection: A case report
6. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells
7. Endothelial cell alloantigens
8. Endothelial-monocyte antigens
9. A mixed antiglobulin test with kidney cells in suspension for IgG antibody in human allograft recipients
10. Individual and strain differences in renal basement membrane antigens
11. Antibodies against renal endothelial alloantigens
12. Serological characterization of antibodies eluted from chronically rejected human renal allografts
13. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium
14. An association between antibodies specific for endothelial cells and renal transplant failure
15. Humoral rejection in two HLA identical living related donor kidney transplants
16. A second lineage of mammalian major histocompatibility complex class I genes
17. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB
18. Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes
19. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients
20. The use of magnetic beads coated with soluble HLA class I or class II proteins in antibody screening and for specificity determinations of donor-reactive antibodies
21. Human natural antibodies cytotoxic to pig embryonic brain cells recognize novel nonGalalpha 1,3Gal-based xenoantigens
22. The clinical significance of allospecific antibodies against endothelial cells detected with an antibody-dependent cellular cytotoxicity assay for vascular rejection and graft loss after renal transplantation
23. Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia
24. Immunobiology of human vascular endothelium
25. Endothelial cell activation and thromboregulation during xenograft rejection
26. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation
27. Population study of allelic diversity in the human MHC class I-related MIC-A gene
28. MICA/MICB expression in renal transplants
29. Implication of gammadelta T cells in the human immune response to cytomegalovirus
30. An activating immunoreceptor complex formed by NKG2D and DAP10